U.S. flag An official website of the United States government
  1. Home
  2. Emergency Preparedness and Response
  3. Counterterrorism and Emerging Threats
  4. Coronavirus Disease 2019 (COVID-19)
  5. Moderna COVID-19 Vaccine
  1. Coronavirus Disease 2019 (COVID-19)

Moderna COVID-19 Vaccine

August 12, 2021: FDA authorizes additional vaccine dose for certain immunocompromised people. View press release.

August 18, 2021: FDA supports the Administration’s work to plan for the deployment of additional vaccine doses, or boosters, this fall. FDA will undertake an independent scientific evaluation of the safety and effectiveness of boosters for each vaccine. View joint statement.

On December 18, 2020, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On June 25, 2021, the FDA revised the patient and provider fact sheets regarding the suggested increased risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination. On August 12, 2021, the FDA amended the Moderna COVID-19 Vaccine EUA to allow for an additional dose to be given to certain immunocompromised individuals. The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.


 
Emergency Use Authorization Status:
Authorized
Name:
Moderna COVID-19 Vaccine
Manufacturer:
ModernaTX, Inc.

Authorized Use

For the prevention of 2019 coronavirus disease (COVID-19) for individuals 18 years of age and older

Common Side Effects

The most commonly reported side effects, which typically lasted several days, were pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, swollen lymph nodes in the same arm as the injection, nausea and vomiting, and fever. Of note, more people experienced these side effects after the second dose than after the first dose, so it is important for vaccination providers and recipients to expect that there may be some side effects after either dose, but even more so after the second dose. Learn more.

Fact Sheets (English) and FAQs

Regulatory Information

Information Date
Letter Granting EUA Amendment August 30, 2021
Letter of Authorization (Reissued) August 12, 2021
Decision Memorandum August 12, 2021
Letter Granting EUA Amendment June 25, 2021
Letter Granting EUA Amendment April 1, 2021
FDA Decision Memorandum December 18, 2020
Advisory Committee Meeting Information December 17, 2020

Media Materials and Webcasts

Information Date
Press Release August 12, 2021
Press Release April 1, 2021
Press Release December 18, 2020
Media Call December 18, 2020
Advisory Committee Webcast December 17, 2020

Translations of the Fact Sheet for Recipients and Caregivers

Fact Sheet Language
ورقة ح قائقل متلقّي اللقاح ومن یرعاھم
(December 2020)
عربي (Arabic)
ကာကွယ်ဆ ေး လက်ခံရရှှိသူမ ာေးနှင ် ဆ ာင ်ဆရှာက်မှု ဆ ေးသူမ ာေးအတွက် သတင်ေးအခ က်အလက် ာရွက်
(December 2020)
မြန်မာ (Burmese)
ᎤᏙᎯᏳ ᎪᏪᎳᏅ ᎾᏍᎩᎾ ᏗᏂᏁᏍᎩ ᎠᎴ ᎤᎾᏓᎦᏎᏍᏗ ᏗᎾᏓᏍᏕᎵᏍᎩ
(December 2020)
ᎩᎵᏏ (Cherokee)
供接受疫苗者和照顾者使用的情况说明书
(December 2020)
中文 (Chinese)
TAROPWEN AFFAT (IKA FACT SHEET) REN CHON ANGEI ME CHON TUMUN
(December 2020)
Foosun Chuuk (Chuukese)
برگه اطالعات برای دریافت کنندگان و ارائه کنندگان مراقبت
(December 2020)
فارسی (Farsi)
FEUILLET D’INFORMATION À L’INTENTION DES PERSONNES RECEVANT LE VACCIN ET DES AIDANTS
(December 2020)
Français (French Canadian)
ERKBLATT FÜR EMPFÄNGER UND BETREUER
(December 2020))
Deutsch (German)
પ્રાપ્તકતાા અને સંભાળ રાખનારાઓ માટે ફેક્ટશીટ
(December 2020)
ગુજરાતી (Gujarati)
FEY ENFOMASYON POU MOUN K’AP RESEVWA AVEK MOUN K’AP BAY SWEN
(December 2020)
Kreyòl Ayisyen (Haitian Creole)
प्राप्तकतााओं और देखभाल कतााओं के ललए तथ्य पत्र
(December 2020)
हिन्दी (Hindi)
DAIM NTAWV QHIA TSEEB RAU COV NEEG TAU KEV PAB THIAB COV NEEG ZOV TU
(December 2020)
Hmoob (Hmong)
SCHEDA INFORMATIVA PER RICEVENTI E ASSISTENTI
(December 2020)
Italiano (Italian)
ZIEN JAUV-LOUC BUN DUQV ZIPV TENGX CAUX ZIUX GOUX NYEI MIENH
(December 2020)
Ang^gitc Waac (Iu Mien)
ワクチン接種を受ける人と介護従事者のためのファクトシート
(December 2020)
日本 (Japanese)
환자와 의료진을 위한 정보지
(December 2020)
한국어 (Korean)
TQANIL YOL TE KYE Q’ANIL IX QE XJAL TUN TOK KYB’AQ
(December 2020)
Tuj qyol (Mam)
PEPA IM MEḶEḶE KO REṂOOL ÑAN RO REJ LOLOORJAKE ĀJMUUR IM
(December 2020)
Pālle (Marshallese)
BĄĄH Á’ÁLNÉHÍÍ DÓÓ AA’ÁHÁLYÁNÍÍ BÁ NAALTSOOS BEE ÉÉHÓZINII
(December 2020)
Bilagáanaa Bizaad jí (Navajo)
ARKUSZ INFORMACYJNY DLA OSÓB SZCZEPIONYCH I ICH OPIEKUNÓW
(December 2020)
Polski (Polish)
FICHA TÉCNICA PARA RECEPTORES E CUIDADORES
(December 2020)
Português (Portuguese)
ИНФОРМАЦИОННЫЙ БЮЛЛЕТЕНЬ ДЛЯ РЕЦИПИЕНТОВ И СПЕЦИАЛИСТОВ ПО УХОДУ
(December 2020)
Русский (Russian)
XAASHIDA MACLUUMAADKA EE LOOGU TALAGALAY DADKA LA
(December 2020)
Soomaali (Somali)
HOJA INFORMATIVA PARA RECEPTORES Y CUIDADORES
(August 27, 2021)
Español (Spanish)
FACT SHEET PARA SA MGA TUMATANGGAP AT TAGAPAG-ALAGA
(December 2020)
Tagalog (Tagalog)
TỜ THÔNG TIN DÀNH CHO NGƯỜI ĐƯỢC TIÊM VẮC-XIN VÀ NGƯỜI CHĂM SÓC
(December 2020)
Tiếng Việt (Vietnamese)
אינפאָרמאַציע בלאט פאר די וועלכע באקומע ן די וואַקסין און פאר הילפער (גבאים)
(December 2020)
אידיש (Yiddish)

Translations of the Fact Sheet for Healthcare Providers Administering Vaccine

Back to Top